Effect of in vitro produced transfer factor on the immune response of cancer patients.
D000230:Adenocarcinoma / Q000276:immunology / Q000628:therapy*; D000368:Aged; D002295:Carcinoma, Transitional Cell / Q000276:immunology / Q000628:therapy*; D002464:Cell Migration Inhibition; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000276:immunology / Q000628:therapy*; D008228:Lymphoma, Non-Hodgkin / Q000276:immunology; D008297:Male; D008875:Middle Aged; D012397:Rosette Formation; D014165:Transfer Factor / Q000627:therapeutic use*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D014165:Transfer Factor